Discover
CMMB
Chemomab Therapeutics Ltd.
2.61
5 x 1.40
5 x 3.40
bid
ask
-
0.19
6.79%
5 @ 07:30 PM
2.66 +0.05 (1.92%)
| Ytd | 58.18% | |
| 1y | -0.76% |
2.57
day range
2.88
1.36
52 week range
3.50
| Open | 2.73 | Prev Close | 2.80 | Low | 2.57 | High | 2.88 | Mkt Cap | 19.13M |
| Vol | 175.83K | Avg Vol | 154.83K | EPS | -0.96 | P/E | N/A | Forward P/E | -41.25 |
| Beta | 0.30 | Short Ratio | 1.15 | Inst. Own | 27.99% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-25 | 50-d Avg | 2.03 | 200-d Avg | 1.84 | 1yr Est | 8.00 |
| Income Statement | |||
| Operating Expenses | 2.24M | ||
| Research and Development Expense | 1.14M | ||
| Selling, General and Administrative Expense | 1.10M | ||
| Operating Income | -2.24M | ||
| Net Income | -2.16M | ||
| Net Income Common Stock | -2.16M | ||
| Net Income Common Stock (USD) | -2.16M | ||
| Consolidated Income | -2.16M | ||
| Earnings per Basic Share | -0.24 | ||
| Earnings per Basic Share (USD) | -0.24 | ||
| Earnings per Diluted Share | -0.24 | ||
| Earning Before Interest & Taxes (EBIT) | -2.16M | ||
| Earning Before Interest & Taxes (USD) | -2.16M | ||
| Weighted Average Shares | 640.24M | ||
| Weighted Average Shares Diluted | 640.24M | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.00M | ||
| Cash and Equivalents (USD) | 6.00M | ||
| Investments | 688.00K | ||
| Investments Current | 688.00K | ||
| Trade and Non-Trade Receivables | 3.27M | ||
| Current Assets | 9.96M | ||
| Property, Plant & Equipment Net | 158.00K | ||
| Total Assets | 10.24M | ||
| Current Liabilities | 1.55M | ||
| Total Liabilities | 1.55M | ||
| Accumulated Retained Earnings (Deficit) | -115.56M | ||
| Shareholders Equity | 8.69M | ||
| Shareholders Equity (USD) | 8.69M | ||
| Assets Non-Current | 281.00K | ||
| Trade and Non-Trade Payables | 257.00K | ||